BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23992637)

  • 1. Osteopontin is associated with decreased apoptosis and αv integrin expression in lung adenocarcinoma.
    Štemberger C; Matušan-Ilijaš K; Avirović M; Bulat-Kardum L; Ivančić A; Jonjić N; Lučin K
    Acta Histochem; 2014 Jan; 116(1):222-9. PubMed ID: 23992637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Over-expression of osteopontin in non-small cell lung cancers: its clinical significance].
    Hu Z; Xiao T; Lin DM; Guo SP; Zhang ZQ; Di XB; Cheng SJ; Gao YN
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):591-5. PubMed ID: 18210878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin knockdown inhibits αv,β3 integrin-induced cell migration and invasion and promotes apoptosis of breast cancer cells by inducing autophagy and inactivating the PI3K/Akt/mTOR pathway.
    Zhang H; Guo M; Chen JH; Wang Z; Du XF; Liu PX; Li WH
    Cell Physiol Biochem; 2014; 33(4):991-1002. PubMed ID: 24714122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of osteopontin and integrin αv in laryngeal and hypopharyngeal carcinomas associated with differentiation and metastasis.
    Lu JG; Li Y; Li L; Kan X
    J Cancer Res Clin Oncol; 2011 Nov; 137(11):1613-8. PubMed ID: 21853313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of osteopontin and CD44v6 in odontogenic keratocysts.
    Wang YP; Liu BY
    J Formos Med Assoc; 2009 Apr; 108(4):286-92. PubMed ID: 19369175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and prognostic significance of OPN and VEGF expression in patients with non-small-cell lung cancer.
    Lin Q; Guo L; Lin G; Chen Z; Chen T; Lin J; Zhang B; Gu X
    Cancer Epidemiol; 2015 Aug; 39(4):539-44. PubMed ID: 26123318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer.
    Rouanne M; Adam J; Goubar A; Robin A; Ohana C; Louvet E; Cormier J; Mercier O; Dorfmüller P; Fattal S; de Montpreville VT; Lebret T; Dartevelle P; Fadel E; Besse B; Olaussen KA; Auclair C; Soria JC
    BMC Cancer; 2016 Jul; 16():483. PubMed ID: 27422280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between the expression of the extracellular matrix genes SPARC, SPP1, FN1, ITGA5 and ITGAV and clinicopathological parameters of tumor progression and colorectal cancer dissemination.
    Viana Lde S; Affonso RJ; Silva SR; Denadai MV; Matos D; Salinas de Souza C; Waisberg J
    Oncology; 2013; 84(2):81-91. PubMed ID: 23128103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrin αv promotes proliferation by activating ERK 1/2 in the human lung cancer cell line A549.
    Fu S; Fan L; Pan X; Sun Y; Zhao H
    Mol Med Rep; 2015 Feb; 11(2):1266-71. PubMed ID: 25370835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of osteopontin, αvβ3 and Pim-1 associated with prognostically important clinicopathologic variables in non-small cell lung cancer.
    Jin Y; Tong DY; Chen JN; Feng ZY; Yang JY; Shao CK; Li JP
    PLoS One; 2012; 7(10):e48575. PubMed ID: 23119061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ameliorating Effect of Osteopontin on H
    Mazaheri N; Peymani M; Galehdari H; Ghaedi K; Ghoochani A; Kiani-Esfahani A; Nasr-Esfahani MH
    Cell Mol Neurobiol; 2018 May; 38(4):891-899. PubMed ID: 29110207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OPN binds alpha V integrin to promote endothelial progenitor cell incorporation into vasculature.
    Wing TT; Erikson DW; Burghardt RC; Bazer FW; Bayless KJ; Johnson GA
    Reproduction; 2020 Apr; 159(4):465-478. PubMed ID: 31990676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin increases lung cancer cells migration via activation of the alphavbeta3 integrin/FAK/Akt and NF-kappaB-dependent pathway.
    Fong YC; Liu SC; Huang CY; Li TM; Hsu SF; Kao ST; Tsai FJ; Chen WC; Chen CY; Tang CH
    Lung Cancer; 2009 Jun; 64(3):263-70. PubMed ID: 18996613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of osteopontin and its receptors in ameloblastomas.
    Wang YP; Liu BY
    Oral Oncol; 2009 Jun; 45(6):538-42. PubMed ID: 18804406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of integrin αv in the human nasopharyngeal carcinoma associated with metastasis and progression.
    Xuan SH; Zhou YG; Pan JQ; Zhu W; Xu P
    Cancer Biomark; 2013; 13(5):323-8. PubMed ID: 24440971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteopontin combined with CD44v6, a novel prognostic biomarker in non-small cell lung cancer undergoing curative resection.
    Sun BS; Li Y; Zhang ZF; You J; Wang CL
    Ann Thorac Surg; 2013 Dec; 96(6):1943-51. PubMed ID: 24094519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of osteopontin expression in human gastric carcinoma.
    Higashiyama M; Ito T; Tanaka E; Shimada Y
    Ann Surg Oncol; 2007 Dec; 14(12):3419-27. PubMed ID: 17896150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. αv-Integrin isoform expression in primary human tumors and brain metastases.
    Vogetseder A; Thies S; Ingold B; Roth P; Weller M; Schraml P; Goodman SL; Moch H
    Int J Cancer; 2013 Nov; 133(10):2362-71. PubMed ID: 23661241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin is a novel prognostic biomarker in early-stage non-small cell lung cancer after surgical resection.
    Yan CH; Lv M; Li H; Song X; Yan F; Cao S; Ren X
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1371-8. PubMed ID: 25555465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin is a prognostic biomarker in non-small cell lung cancer.
    Rud AK; Boye K; Oijordsbakken M; Lund-Iversen M; Halvorsen AR; Solberg SK; Berge G; Helland A; Brustugun OT; Mælandsmo GM
    BMC Cancer; 2013 Nov; 13():540. PubMed ID: 24215488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.